Literature DB >> 25725080

Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma--a long-term follow-up study.

B Kasenda1, E Schorb2, K Fritsch2, J Finke2, G Illerhaus2.   

Abstract

Entities:  

Year:  2015        PMID： 25725080     DOI： 10.1093/annonc/mdv002

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  10 in total

1.  High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective study.

Authors:  E Schorb; C P Fox; K Fritsch; L Isbell; A Neubauer; A Tzalavras; R Witherall; S Choquet; O Kuittinen; D De-Silva; K Cwynarski; C Houillier; K Hoang-Xuan; V Touitou; N Cassoux; J-P Marolleau; J Tamburini; R Houot; V Delwail; G Illerhaus; C Soussain; B Kasenda
Journal:  Bone Marrow Transplant       Date:  2017-04-24       Impact factor: 5.483

2.  Identifying targetable genetic features in primary CNS lymphoma.

Authors:  Agnieszka Korfel; Uwe Schlegel
Journal:  Int J Hematol Oncol       Date:  2017-01-13

3.  Role of radiation therapy in primary central nervous system lymphoma : KROG 14-20 Collaborative Study of Brain and Lymphoma Committee.

Authors:  Hyeon Kang Koh; Il Han Kim; Tae Min Kim; Do Hoon Lim; Dongryul Oh; Jae Ho Cho; Woo-Chul Kim; Jin Hee Kim; Woong-Ki Chung; Bae-Kwon Jeong; Ki Mun Kang; Semie Hong; Chang-Ok Suh; In Ah Kim
Journal:  J Neurooncol       Date:  2017-09-22       Impact factor: 4.130

4.  Long-term remission of subcutaneous panniculitis-like T-cell lymphoma with central nervous system involvement: A case report.

Authors:  Yajuan Qiu; Dandan Zhang; Mingzhi Zhang
Journal:  Oncol Lett       Date:  2016-05-26       Impact factor: 2.967

5.  Management and outcome of primary CNS lymphoma in the modern era: An LOC network study.

Authors:  Caroline Houillier; Carole Soussain; Hervé Ghesquières; Pierre Soubeyran; Olivier Chinot; Luc Taillandier; Thierry Lamy; Sylvain Choquet; Guido Ahle; Gandhi Damaj; Philippe Agapé; Cécile Moluçon-Chabrot; Alexandra Amiel; Vincent Delwail; Michel Fabbro; Fabrice Jardin; Adrien Chauchet; Marie-Pierre Moles-Moreau; Franck Morschhauser; Olivier Casasnovas; Rémy Gressin; Luc-Matthieu Fornecker; Julie Abraham; Jean-Pierre Marolleau; Adrian Tempescul; Chantal Campello; Philippe Colin; Jérôme Tamburini; Kamel Laribi; Caroline Serrier; Corinne Haioun; Safia Chebrek; Anna Schmitt; Marie Blonski; Roch Houot; Eileen Boyle; Jacques-Olivier Bay; Lucie Oberic; Emeline Tabouret; Agathe Waultier; Nadine Martin-Duverneuil; Valérie Touitou; Nathalie Cassoux; Aurélie Kas; Karima Mokhtari; Frederic Charlotte; Agusti Alentorn; Loïc Feuvret; Magali Le Garff-Tavernier; Myrto Costopoulos; Bertrand Mathon; Matthieu Peyre; Daniel Delgadillo; Hassen Douzane; Diane Genet; Bachir Aidaoui; Khê Hoang-Xuan; Emmanuel Gyan
Journal:  Neurology       Date:  2020-01-06       Impact factor: 9.910

6.  Efficacy and Safety of Autologous Stem-Cell Transplantation as Part of First-Line Treatment for Newly Diagnosed Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis.

Authors:  Jing Liu; Jiayuan Guo; Xuefei Sun; Yuanbo Liu; Chunji Gao
Journal:  Front Oncol       Date:  2022-01-12       Impact factor: 6.244

7.  First-line high-dose therapy and autologous blood stem cell transplantation in patients with primary central nervous system non-Hodgkin lymphomas-a single-centre experience in 61 patients.

Authors:  T Brezina; H von Dewitz; T Schroeder; S Ullrich; K Nachtkamp; G Reifenberger; B Malzkorn; M Sabel; R Haas; G Kobbe
Journal:  Ann Hematol       Date:  2022-01-04       Impact factor: 3.673

8.  Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma.

Authors:  Julia Wendler; Christopher P Fox; Elisabeth Schorb; Gerald Illerhaus; Elke Valk; Cora Steinheber; Heidi Fricker; Lisa K Isbell; Simone Neumaier; Jessica Okosun; Florian Scherer; Gabriele Ihorst; Kate Cwynarski
Journal:  BMC Cancer       Date:  2022-09-10       Impact factor: 4.638

9.  Primary central nervous system lymphoma: Retrospective analysis of 34 cases in a single centre.

Authors:  Huafeng Wang; Ming Wang; Juying Wei; Lei Wang; Liping Mao; Jie Jin
Journal:  J Int Med Res       Date:  2017-10-06       Impact factor: 1.671

10.  Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNS.

Authors:  Sarah J Nagle; Nirav N Shah; Alex Ganetsky; Daniel J Landsburg; Sunita D Nasta; Anthony Mato; Stephen J Schuster; Ran Reshef; Donald E Tsai; Jakub Svoboda
Journal:  Int J Hematol Oncol       Date:  2018-01-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.